Study on The Expressions of Matrix Metalloproteinase-26 and Sialyl Lewis-X in Breast Carcinoma
- VernacularTitle:基质金属蛋白酶-26和唾液酸化Lewis-X蛋白在乳腺癌中的表达及其意义
- Author:
Peizhong SHANG
;
Jinjiang ZHANG
;
Jingzhang LIU
;
Huaping GU
- Publication Type:Journal Article
- Keywords:
Breast carcinoma Matrix metalloproteinase-26 Sialyl Lewis-X antigen Infiltration Metastasis
- From:
Chinese Journal of Bases and Clinics in General Surgery
2008;0(07):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expressions of matrix metalloproteinase-26(MMP-26) and sialyl Lewis-X(SLeX) in breast carcinoma and their relation with lymphaden metastasis.Methods The expressions of MMP-26 and SLeX protein in breast carcinoma(n=120),metastatic lymph node(n=71) and normal mammary gland tissue(n=30) were studied by catalyzed signal amplification(CSA) immunohistochemical method.Results The positive rate of MMP-26 and SLeX protein expression were 16.7%(5/30) and 20.0%(6/30) in normal breast tissues,and 63.3%(76/120) and 86.7%(104/120) in breast carcinoma,resepectively.The expressions of MMP-26 and SLeX protein in breast carcinoma tissues were significantly higher than those in remote normal breast tissues(P0.05).The positive rate of MMP-26 and SLeX protein expression were 23.9%(17/71) and 88.7%(63/71) in metastatic lymph node,resepectively.The expression of SLeX protein in metastatic lymph node was correlated with that in tissues of breast carcinoma(r=0.874,P
